Skip to main content


Strahlentherapie und Onkologie

Strahlentherapie und Onkologie 7/2020

Ausgabe 7/2020

Inhaltsverzeichnis ( 12 Artikel )

12.03.2020 | Review Article | Ausgabe 7/2020 Open Access

Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer

Statement from the DEGRO working group prostate cancer
Pirus Ghadjar MD, Daniel M. Aebersold, Clemens Albrecht, Dirk Böhmer, Michael Flentje, Ute Ganswindt, Stefan Höcht, Tobias Hölscher, Arndt-Christian Müller, Peter Niehoff, Michael Pinkawa, Felix Sedlmayer, Daniel Zips, Thomas Wiegel, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and The Working Party Radiation Oncology of the German Cancer Society (DKG-ARO)

10.02.2020 | Original Article | Ausgabe 7/2020 Open Access

Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities

Stratos Vassis, Beatrice Nöldeke M.Sc., Prof. Dr. med. Hans Christiansen, PD Dr. med. Christoph A. von Klot, Dr. med. Roland Merten

17.04.2020 | Original Article | Ausgabe 7/2020

Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer

Long-term results and factors predictive for outcome and toxicity
Assistant Professor Ciro Franzese MD, Marco Badalamenti, Lucia Di Brina, Giuseppe D’Agostino, Davide Franceschini, Tiziana Comito, Elena Clerici, Pierina Navarria, Giacomo Reggiori, Pietro Mancosu, Stefano Tomatis, Full Professor Marta Scorsetti

12.03.2020 | Original Article | Ausgabe 7/2020

Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer+

Franco Campostrini MD, Andrea Remo MD, Laura Astati BS, Manuel Zorzi MD, Giulia Capodaglio ScD, Alberto Buffoli MD, Gaia Moretti M Ph, Barbara Della Monica M Ph, Caterina Zanella MD, Giuseppe Verlato PhD

12.05.2020 | Original Article | Ausgabe 7/2020

Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer

Dr. Francesco Cuccia, Luca Nicosia, Rosario Mazzola, Vanessa Figlia, Niccolò Giaj-Levra, Francesco Ricchetti, Michele Rigo, Claudio Vitale, Stefanie Corradini, Ruggero Ruggieri, Filippo Alongi

24.03.2020 | Original Article | Ausgabe 7/2020 Open Access

PSMA-positive nodal recurrence in prostate cancer

Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
Dr. med. Nina-Sophie Schmidt-Hegemann, PD Dr. med. Alexander Buchner, Dr. med. Chukwuka Eze, Dr. med. Paul Rogowski, Christian Schaefer, Dr. med. Harun Ilhan, Dr. med. Minglun Li, PD Dr. med. Wolfgang Peter Fendler, Prof. Dr. med. Peter Bartenstein, Prof. Dr. med. Ute Ganswindt, Prof. Dr. med. Christian Stief, Prof. Dr. med. Claus Belka, PD Dr. med. Alexander Kretschmer

10.03.2020 | Original Article | Ausgabe 7/2020 Open Access

Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients

Felix Böckelmann M.Sc., Florian Putz M.D., Karoline Kallis Ph.D., Sebastian Lettmaier M.D., Rainer Fietkau M.D., Prof. Dr. Christoph Bert Ph.D.

13.01.2020 | Original Article | Ausgabe 7/2020

Duration-dependent margins for prostate radiotherapy—a practical motion mitigation strategy

Eric Pei Ping Pang PhD, Kellie Knight HScD, Sung Yong Park PhD, Weixiang Lian BSc, Zubin Master MSc, Marilyn Baird PhD, Jason Wei Xiang Chan BSc, Michael Lian Chek Wang MBBS, Terence Wee Kiat Tan MBBS, Melvin L. K. Chua PhD, Eu Tiong Chua MBBS, Wen Shen Looi MBBS, Wen Long Nei MBBS, Jeffrey Kit Loong Tuan MBBS

31.01.2020 | Case Study | Ausgabe 7/2020

An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report

Alexander D. Sherry, Michael Bezzerides, Mohamed H. Khattab, Guozhen Luo, Kristin K. Ancell, Austin N. Kirschner MD, PhD

16.04.2020 | Mammakarzinom | Literatur kommentiert | Ausgabe 7/2020 Open Access

Adjuvante Radiotherapie beim Niedrigrisikomammakarzinom: Langzeitergebnisse der ABCSG-8A-Studie

Dr. David Krug, PD Dr. Marciana-Nona Duma

22.04.2020 | Prostatakarzinom | Literatur kommentiert | Ausgabe 7/2020

Intensitätsmodulierte fraktionierte Radiotherapie vs. körperstereotaktische Radiotherapie des Prostatakarzinoms (PACE-B) – akute Toxizität aus einer internationalen, randomisierten Phase-III-Nichtunterlegenheitsstudie

Prof. Dr. med. Gerhard G. Grabenbauer

15.04.2020 | Oropharynxkarzinom | Literatur kommentiert | Ausgabe 7/2020 Open Access

Zirkulierende HPV-Tumor-DNA als möglicher Biomarker in der Rezidivdiagnostik des HPV-assoziierten Oropharynxkarzinoms

Dr. med. Alexander Rühle, PD Dr. Dr. med. Nils H. Nicolay

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.